Emergent BioSolutions, Inc. have confirmed acquisition

Emergent BioSolutions Inc have confirmed their acquisition of the Healthcare Protective Products Division of Bracco USA Inc, manufacturers of RSDL®

Emergent BioSolutions is a public corporation traded on the New York Stock Exchange and currently supplies BioThrax®, the world’s only anthrax vaccine licensed in the United States, Singapore and Germany. With the acquisition, Emergent will become the source for RSDL®, Reactive Skin Decontamination Lotion – a patented broad spectrum skin decontamination product intended to remove or neutralise chemical warfare agents or T2 toxin from the skin, leaving a non-toxic liquid that can be washed away with water.

Tags: Chemical, Decontamination, Warfare

Our Current Sponsors

  • 908 Devices
  • Airboss
  • Argon
  • Avon
  • Battelle
  • Biofire Idaho
  • Bruker
  • Bw Tek
  • Cap Force 1 Decon 01
  • CQC
  • Cristanini
  • Decon Seven Systems
  • DQE
  • Dxterity
  • Emergent Biosol
  • Endeavor Roborics
  • Ecotest
  • Federal Resources
  • First Line Technology
  • Flir
  • Futurtech
  • Hameln
  • Metrohm Raman
  • NBC sys
  • Proengin
  • Qinetiq
  • RSDecon
  • Tex Shield
  • Wl Gore